person · Reporting owner

Norden Gregory

Disclosed activity across 5 companies

Tapewire entity: 38736
SEC CIK: 0001405104

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Entasis Therapeutics Holdings Inc.ETTX · Entity 16036	Director	June 19, 2019	June 21, 2019
Praxis Precision Medicines, Inc.PRAX · Entity 3538	Director	June 10, 2026	June 12, 2026
Royalty Pharma plcRPRX · Entity 3100	Director	June 05, 2026	June 08, 2026
Zoetis Inc.ZTS · Entity 679	Director	March 09, 2026	March 10, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Entasis Therapeutics Holdings Inc.

Report date June 19, 2019 · Filed June 21, 2019

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.12 · Expires 2029-06-18	Direct	7,500	Reported balance After 2019-06-19 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2019-06-19 · Grant · Acquired 7,500 · Balance 7,500 F1: The shares subject to this option will vest in equal monthly installments over the 12 months following the date of grant, provided that the option will in any case be fully vested on the date of the next annual stockholder meeting, subject to the Reporting Persons's continued service through each such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: The shares subject to this option will vest in equal monthly installments over the 12 months following the date of grant, provided that the option will in any case be fully vested on the date of the next annual stockholder meeting, subject to the Reporting Persons's continued service through each such vesting date.

Praxis Precision Medicines, Inc.

Report date June 10, 2026 · Filed June 12, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,559	Reported balance After 2026-06-10 transaction · row 1 1 source row Row 1 · 2026-06-10 · Grant · Acquired 1,371 · Balance 1,559 F1: Mr. Norden was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $240.66 · Expires 2036-06-10	Direct	648	Reported balance After 2026-06-10 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-06-10 · Grant · Acquired 648 · Balance 648 F2: The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

Filing footnotes · ownership attribution and instrument terms

F1: Mr. Norden was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

F2: The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

Royalty Pharma plc

Report date June 05, 2026 · Filed June 08, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Ordinary SharesSEC Table I · non-derivative	Direct	196,348	Reported balance After 2026-06-05 transaction · row 1 1 source row Row 1 · 2026-06-05 · Grant · Acquired 4,545 · Balance 196,348 F1: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

Zoetis Inc.

Report date March 09, 2026 · Filed March 10, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2026-03-09 transaction · row 1 1 source row Row 1 · 2026-03-09 · Gift · Disposed 1,213 · Balance 0
Common StockSEC Table I · non-derivative	IndirectBy personal trust	7,071.1922	Reported balance Holding disclosure · report date 2026-03-09 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 7,071.1922 F1: On March 9, 2026, the reporting person transferred 1,213 shares of Zoetis common stock to a trust of which the reporting person is a trustee.
Common StockSEC Table I · non-derivative	IndirectBy daughter's trust	5,548	Reported balance Holding disclosure · report date 2026-03-09 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 5,548
Common StockSEC Table I · non-derivative	IndirectBy son's trust	5,548	Reported balance Holding disclosure · report date 2026-03-09 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 5,548

Filing footnotes · ownership attribution and instrument terms

F1: On March 9, 2026, the reporting person transferred 1,213 shares of Zoetis common stock to a trust of which the reporting person is a trustee.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

NanoString Technologies Inc

Report date May 06, 2024 · Filed May 08, 2024

Section 16 reporting ended · disclosed 2024-05-08. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	88,552	Reported balance After 2024-05-06 transaction · row 1 1 source row Row 1 · 2024-05-06 · Exercise / conversion · Acquired 41,133 · Balance 88,552 F1: The shares have not been delivered to the reporting person.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2024-05-06 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2024-05-06 · Exercise / conversion · Disposed 41,133 · Balance 0 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F3: Pursuant to the terms of the award, as a result of the closing of the sale of substantially all of the assets of the Company to Bruker Corporation, which constituted a "Change of Control" under the terms of the RSU award agreement, the vesting of the RSUs accelerated.

Filing footnotes · ownership attribution and instrument terms

F1: The shares have not been delivered to the reporting person.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock.

F3: Pursuant to the terms of the award, as a result of the closing of the sale of substantially all of the assets of the Company to Bruker Corporation, which constituted a "Change of Control" under the terms of the RSU award agreement, the vesting of the RSUs accelerated.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 17, 2022 Filed Jun 17, 2022 17:09 UTC	NanoString Technologies Inc NSTG · Entity 15988	GrantCommon Stock · Derivative	14,851	$0.00	$0.00	Disclosure SEC source: 0001401708-22-000124 · wf-form4_165550016783122.xml · derivative · entry 3 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,851 Underlying: Common Stock · 14,851 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F3 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 17, 2022 or on the date immediately prior to the 2023 annual meeting of stockholders. F3 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 17, 2022 or on the date immediately prior to the 2023 annual meeting of stockholders. Read SEC document
June 16, 2022 Filed Jun 17, 2022 17:09 UTC	NanoString Technologies Inc NSTG · Entity 15988	Exercise / conversionCommon Stock · Derivative	3,890	$0.00	$0.00	Disclosure SEC source: 0001401708-22-000124 · wf-form4_165550016783122.xml · derivative · entry 2 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,890 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F2 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders. F2 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders. Read SEC document
June 16, 2022 Filed Jun 17, 2022 17:09 UTC	NanoString Technologies Inc NSTG · Entity 15988	Exercise / conversionCommon Stock	3,890	$0.00	$0.00	Disclosure SEC source: 0001401708-22-000124 · wf-form4_165550016783122.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 26, 2022 Filed May 27, 2022 21:25 UTC	Praxis Precision Medicines, Inc. PRAX · Entity 3538	GrantStock Option (Right to Buy) · Derivative	22,753	$0.00 Strike: $8.38	$0.00	Disclosure SEC source: 0001689548-22-000063 · wf-form4_165368667461252.xml · derivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,753 Underlying: Common Stock · 22,753 shares Expires 2032-05-26 F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on May 26, 2022. Read SEC document
February 12, 2022 Filed Feb 15, 2022 19:57 UTC	Zoetis Inc. ZTS · Entity 679	Exercise / conversionRestricted Stock Unit · Derivative	2,673.1237	Not disclosed	Not disclosed	Disclosure SEC source: 0001555280-22-000103 · wf-form4_164497301193161.xml · derivative · entry 6 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,244.8149 Underlying: Common Stock · 2,673.1237 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,673.1237 RSUs vested on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,673.1237 RSUs vested on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,673.1237 RSUs vested on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025. Read SEC document
February 12, 2022 Filed Feb 15, 2022 19:57 UTC	Zoetis Inc. ZTS · Entity 679	OtherCommon Stock	671	$198.87	$133,441.77	Disclosure SEC source: 0001555280-22-000103 · wf-form4_164497301193161.xml · nonDerivative · entry 2 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,002 F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date. Read SEC document
February 12, 2022 Filed Feb 15, 2022 19:57 UTC	Zoetis Inc. ZTS · Entity 679	Exercise / conversionCommon Stock	2,673	Not disclosed	Not disclosed	Disclosure SEC source: 0001555280-22-000103 · wf-form4_164497301193161.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document
February 08, 2022 Filed Feb 10, 2022 18:40 UTC	Zoetis Inc. ZTS · Entity 679	GrantRestricted Stock Unit · Derivative	1,192	$0.00	$0.00	Disclosure SEC source: 0001555280-22-000061 · wf-form4_164453639646445.xml · derivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,917.9386 Underlying: Common Stock · 1,192 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,673.1237 RSUs will vest on February 12, 2022; 1,613.9322 RSUs will vest on February 11, 2023; 1,438.8827 RSUs will vest on February 10, 2024; and 1,192 RSUs will vest on February 8, 2025. Read SEC document
November 05, 2021 Filed Nov 9, 2021 16:48 UTC	Zoetis Inc. ZTS · Entity 679	SaleCommon Stock	4,500	$216.07	$972,315.00	Disclosure SEC source: 0001555280-21-000336 · wf-form4_163649445097012.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By personal trust Disclosed balance after: 3,899.1922 F1 · shares: Shares were transferred to a personal trust in May 2021. Such transfer constituted a change in form of ownership from direct to indirect and was exempt from Section 16. F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.05 to $216.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: Shares were transferred to a personal trust in May 2021. Such transfer constituted a change in form of ownership from direct to indirect and was exempt from Section 16. Read SEC document
June 25, 2021 Filed Jun 30, 2021 00:26 UTC	Royalty Pharma plc RPRX · Entity 3100	GrantClass A Ordinary Shares	5,726	$0.00	$0.00	Disclosure SEC source: 0000950103-21-009688 · dp153555_4-norden.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,370 F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder. Read SEC document
June 16, 2021 Filed Jun 17, 2021 19:02 UTC	NanoString Technologies Inc NSTG · Entity 15988	GrantCommon Stock · Derivative	3,890	$0.00	$0.00	Disclosure SEC source: 0001401708-21-000178 · wf-form4_162397091334537.xml · derivative · entry 3 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,890 Underlying: Common Stock · 3,890 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F3 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders. F3 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders. Read SEC document
June 15, 2021 Filed Jun 17, 2021 19:02 UTC	NanoString Technologies Inc NSTG · Entity 15988	Exercise / conversionCommon Stock · Derivative	5,520	$0.00	$0.00	Disclosure SEC source: 0001401708-21-000178 · wf-form4_162397091334537.xml · derivative · entry 2 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,520 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F2 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2020 or on the date immediately prior to the 2021 annual meeting of stockholders. F2 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2020 or on the date immediately prior to the 2021 annual meeting of stockholders. Read SEC document
June 15, 2021 Filed Jun 17, 2021 19:02 UTC	NanoString Technologies Inc NSTG · Entity 15988	Exercise / conversionCommon Stock	5,520	Not disclosed	Not disclosed	Disclosure SEC source: 0001401708-21-000178 · wf-form4_162397091334537.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. Read SEC document
June 08, 2021 Filed Jun 9, 2021 21:01 UTC	Praxis Precision Medicines, Inc. PRAX · Entity 3538	GrantStock Option (Right to Buy) · Derivative	22,343	$0.00 Strike: $20.42	$0.00	Disclosure SEC source: 0001689548-21-000059 · wf-form4_162327248575187.xml · derivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,343 Underlying: Common Stock · 22,343 shares Expires 2031-06-08 F1 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments over one (1) year commencing on June 8, 2021. Read SEC document
May 12, 2021 Filed Jul 7, 2021 21:15 UTC	Praxis Precision Medicines, Inc. PRAX · Entity 3538	OtherCommon Stock	2,826	$0.00	$0.00	Disclosure SEC source: 0001689548-21-000068 · wf-form4_162569250878909.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,826 F1 · kind: Pro rata distribution from Clarus Lifesciences III, L.P., of which the reporting person is a limited partner. Read SEC document
February 13, 2021 Filed Feb 17, 2021 17:24 UTC	Zoetis Inc. ZTS · Entity 679	Exercise / conversionRestricted Stock Unit · Derivative	2,779.1458	Not disclosed	Not disclosed	Disclosure SEC source: 0001555280-21-000124 · wf-form4_161360064399444.xml · derivative · entry 3 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,694.57 Underlying: Common Stock · 2,779.1458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document
February 13, 2021 Filed Feb 17, 2021 17:24 UTC	Zoetis Inc. ZTS · Entity 679	OtherCommon Stock	697	$166.71	$116,196.87	Disclosure SEC source: 0001555280-21-000124 · wf-form4_161360064399444.xml · nonDerivative · entry 2 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,389.2431 F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date. Read SEC document
February 13, 2021 Filed Feb 17, 2021 17:24 UTC	Zoetis Inc. ZTS · Entity 679	Exercise / conversionCommon Stock	2,779	Not disclosed	Not disclosed	Disclosure SEC source: 0001555280-21-000124 · wf-form4_161360064399444.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,086.2431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document
February 10, 2021 Filed Feb 12, 2021 17:56 UTC	Zoetis Inc. ZTS · Entity 679	GrantRestricted Stock Unit · Derivative	1,431	$0.00	$0.00	Disclosure SEC source: 0001555280-21-000076 · wf-form4_161317055087379.xml · derivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,473.7158 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 2,779.1458 RSUs will vest on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document
December 07, 2020 Filed Dec 9, 2020 16:41 UTC	NanoString Technologies Inc NSTG · Entity 15988	Exercise / conversionStock Option (right to buy) · Derivative	10,406	$1.92 Strike: $1.92	$19,979.52	Disclosure SEC source: 0001401708-20-000224 · wf-form4_160755004540778.xml · derivative · entry 4 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,406 shares Expires 2022-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the shares subject to the Option vest on the one year anniversary of July 17, 2012 (the "Vesting Commencement Date"), and thereafter 1/48th of the shares subject to the Option vest on each monthly annivesary of the Vesting Commencement Date. Read SEC document
December 07, 2020 Filed Dec 9, 2020 16:41 UTC	NanoString Technologies Inc NSTG · Entity 15988	SaleCommon Stock	24	$58.90	$1,413.60	Disclosure SEC source: 0001401708-20-000224 · wf-form4_160755004540778.xml · nonDerivative · entry 3 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,890 Read SEC document
December 07, 2020 Filed Dec 9, 2020 16:41 UTC	NanoString Technologies Inc NSTG · Entity 15988	SaleCommon Stock	10,382	$58.32	$605,478.24	Disclosure SEC source: 0001401708-20-000224 · wf-form4_160755004540778.xml · nonDerivative · entry 2 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,914 F1 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $57.87 to $58.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document
December 07, 2020 Filed Dec 9, 2020 16:41 UTC	NanoString Technologies Inc NSTG · Entity 15988	Exercise / conversionCommon Stock	10,406	$1.92	$19,979.52	Disclosure SEC source: 0001401708-20-000224 · wf-form4_160755004540778.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,296 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 13, 2020 Filed Aug 13, 2020 18:43 UTC	NanoString Technologies Inc NSTG · Entity 15988	SaleCommon Stock	10,000	$38.83	$388,250.00	Disclosure SEC source: 0001401708-20-000157 · wf-form4_159735861201664.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,890 Read SEC document
June 18, 2020 Filed Sep 24, 2020 00:30 UTC	Royalty Pharma plc RPRX · Entity 3100	GrantClass A Ordinary Shares	8,929	$0.00	$0.00	Disclosure SEC source: 0000950103-20-018600 · dp137242_4-norden.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,644 Read SEC document
June 16, 2020 Filed Jun 17, 2020 19:34 UTC	NanoString Technologies Inc NSTG · Entity 15988	GrantRestricted Stock Units · Derivative	5,520	$0.00	$0.00	Disclosure SEC source: 0001401708-20-000131 · wf-form4_159243684702005.xml · derivative · entry 3 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,520 Underlying: Common Stock · 5,520 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of Issuer's common stock. F4 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2020 or on the date immediately prior to the 2021 annual meeting of stockholders. F4 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2020 or on the date immediately prior to the 2021 annual meeting of stockholders. Read SEC document
June 15, 2020 Filed Jun 18, 2020 01:49 UTC	Royalty Pharma plc RPRX · Entity 3100	GrantClass A Ordinary Shares	35,715	$0.00	$0.00	Disclosure SEC source: 0000950103-20-011923 · dp130579_4-norden.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,715 Read SEC document
June 15, 2020 Filed Jun 17, 2020 19:34 UTC	NanoString Technologies Inc NSTG · Entity 15988	Exercise / conversionRestricted Stock Units · Derivative	1,890	$0.00	$0.00	Disclosure SEC source: 0001401708-20-000131 · wf-form4_159243684702005.xml · derivative · entry 2 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,890 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of Issuer's common stock. F3 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 18, 2019 or on the date immediately prior to the 2020 annual meeting of stockholders. F3 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 18, 2019 or on the date immediately prior to the 2020 annual meeting of stockholders. Read SEC document
June 15, 2020 Filed Jun 17, 2020 19:34 UTC	NanoString Technologies Inc NSTG · Entity 15988	Exercise / conversionCommon Stock	1,890	Not disclosed	Not disclosed	Disclosure SEC source: 0001401708-20-000131 · wf-form4_159243684702005.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into Common Stock on a one-for-one basis. Read SEC document
June 15, 2020 Filed Sep 24, 2020 00:30 UTC	Royalty Pharma plc RPRX · Entity 3100	GrantLP interests in RPI US Partners 2019, LP · Derivative	15,594	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950103-20-018600 · dp137242_4-norden.xml · derivative · entry 2 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,594 Underlying: Class A Ordinary Shares · 155,940 shares Expires not disclosed F1 · kind: The Reporting Person acquired beneficial ownership of Class B Interests in Royalty Pharma Holdings, Ltd. ("Holdings") and became entitled to indirect rights to exchange such Class B Interests for Class A Ordinary Shares of the Issuer in connection with a reorganization prior to closing of the Issuer's initial public offering (as more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-238632)). The reorganization involved the exchange of interests in Royalty Pharma Investments 2019 ICAV held by RPI US Partners 2019, LP ("RPI US LP") and RPI International Holdings 2019, LP ("RPI Intl. LP") for interests in Holdings. The reorganization and the acquisition of these exchange rights occurred on June 15, 2020. F2 · derivative.exercise_date: Represents limited partnership interests in RPI US Partners 2019, LP ("RPI US LP Interests"). Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value. F2 · derivative.expiration_date: Represents limited partnership interests in RPI US Partners 2019, LP ("RPI US LP Interests"). Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value. F3 · balance_after: Includes RPI US LP Interests convertible into 11,280 Class A Ordinary Shares that are subject to forfeiture if and when the Class A Ordinary Shares attain a 20-trading day volume weighted average price of $32.30 or more after December 15, 2020 and on or before December 15, 2023. The amount of this forfeiture scales linearly from 0% at $20.51 per share to 100% at $32.30 per share. Read SEC document
April 29, 2020 Filed Sep 15, 2020 16:25 UTC	Zoetis Inc. ZTS · Entity 679	GiftCommon Stock	5,620	$0.00	$0.00	Disclosure SEC source: 0001555280-20-000278 · wf-form4_160020154200980.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,164 Read SEC document
February 14, 2020 Filed Feb 19, 2020 17:36 UTC	Zoetis Inc. ZTS · Entity 679	Exercise / conversionRestricted Stock Unit · Derivative	3,704.6976	Not disclosed	Not disclosed	Disclosure SEC source: 0001555280-20-000120 · wf-form4_158215176434003.xml · derivative · entry 3 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,002.8287 Underlying: Common Stock · 3,704.6976 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: The RSUs vest as follows: 3,704.6976 RSUs vested on February 14, 2020; 2,763.4058 RSUs will vest on February 13, 2021; 2,643.4229 RSUs will vest on February 12, 2022; and 1,596 RSUs will vest on February 11, 2023. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: The RSUs vest as follows: 3,704.6976 RSUs vested on February 14, 2020; 2,763.4058 RSUs will vest on February 13, 2021; 2,643.4229 RSUs will vest on February 12, 2022; and 1,596 RSUs will vest on February 11, 2023. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: The RSUs vest as follows: 3,704.6976 RSUs vested on February 14, 2020; 2,763.4058 RSUs will vest on February 13, 2021; 2,643.4229 RSUs will vest on February 12, 2022; and 1,596 RSUs will vest on February 11, 2023. Read SEC document
February 14, 2020 Filed Feb 19, 2020 17:36 UTC	Zoetis Inc. ZTS · Entity 679	OtherCommon Stock	929	$144.17	$133,933.93	Disclosure SEC source: 0001555280-20-000120 · wf-form4_158215176434003.xml · nonDerivative · entry 2 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,784 F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date. Read SEC document
February 14, 2020 Filed Feb 19, 2020 17:36 UTC	Zoetis Inc. ZTS · Entity 679	Exercise / conversionCommon Stock	3,704	Not disclosed	Not disclosed	Disclosure SEC source: 0001555280-20-000120 · wf-form4_158215176434003.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,713 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document
February 11, 2020 Filed Feb 13, 2020 16:42 UTC	Zoetis Inc. ZTS · Entity 679	GrantRestricted Stock Unit · Derivative	1,596	$0.00	$0.00	Disclosure SEC source: 0001555280-20-000059 · wf-form4_158163013586735.xml · derivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,707.5263 Underlying: Common Stock · 1,596 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 3,704.6976 RSUs will vest on February 14, 2020; 2,763.4058 RSUs will vest on February 13, 2021; 2,643.4229 RSUs will vest on February 12, 2022; and 1,596 RSUs will vest on February 11, 2023. Read SEC document
June 19, 2019 Filed Jun 21, 2019 16:03 UTC	Entasis Therapeutics Holdings Inc. ETTX · Entity 16036	GrantStock Option (Right to Buy) · Derivative	7,500	$0.00 Strike: $6.12	$0.00	Disclosure SEC source: 0001104659-19-037005 · a4.xml · derivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-06-18 F1 · derivative.exercise_date: The shares subject to this option will vest in equal monthly installments over the 12 months following the date of grant, provided that the option will in any case be fully vested on the date of the next annual stockholder meeting, subject to the Reporting Persons's continued service through each such vesting date. Read SEC document
June 18, 2019 Filed Jun 20, 2019 16:13 UTC	NanoString Technologies Inc NSTG · Entity 15988	GrantRestricted Stock Units · Derivative	1,890	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001401708-19-000152 · wf-form4_156106157774032.xml · derivative · entry 2 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,890 Underlying: Common Stock · 1,890 shares Expires not disclosed F2 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F3 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one-year anniversary of June 18, 2019 or the date immediately prior to the 2020 annual meeting of stockholders. F3 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one-year anniversary of June 18, 2019 or the date immediately prior to the 2020 annual meeting of stockholders. Read SEC document
June 18, 2019 Filed Jun 20, 2019 16:13 UTC	NanoString Technologies Inc NSTG · Entity 15988	GrantStock Options (right to buy) · Derivative	3,857	$0.00 Strike: $26.45	$0.00	Disclosure SEC source: 0001401708-19-000152 · wf-form4_156106157774032.xml · derivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,857 Underlying: Common Stock · 3,857 shares Expires 2029-06-18 F1 · derivative.exercise_date: 100% of the shares subject to the Option vest on the earlier of the one-year anniversary of June 18, 2019 or the date immediately prior to the 2020 annual meeting of stockholders. Read SEC document
March 25, 2019 Filed Mar 27, 2019 16:36 UTC	NanoString Technologies Inc NSTG · Entity 15988	GrantCommon Stock · Derivative	4,410	$0.00 Strike: $23.34	$0.00	Disclosure SEC source: 0001401708-19-000117 · wf-form4_155371894938179.xml · derivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,410 Underlying: Common Stock · 4,410 shares Expires 2029-03-25 F1 · derivative.exercise_date: 100% of the shares subject to the Option vest on the the date prior to the day of the Company's 2019 annual meeting of stockholders. Read SEC document
February 19, 2019 Filed Feb 21, 2019 17:25 UTC	Zoetis Inc. ZTS · Entity 679	Exercise / conversionRestricted Stock Unit · Derivative	4,150.3887	Not disclosed	Not disclosed	Disclosure SEC source: 0001555280-19-000106 · wf-form4_155078791845431.xml · derivative · entry 3 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,058.3653 Underlying: Common Stock · 4,150.3887 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,150.3887 RSUs vested on February 19, 2019; 3,683.0826 RSUs will vest on February 14, 2020; 2,747.2827 RSUs will vest on February 13, 2021; and 2,628.0000 RSUs will vest on February 12, 2022. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,150.3887 RSUs vested on February 19, 2019; 3,683.0826 RSUs will vest on February 14, 2020; 2,747.2827 RSUs will vest on February 13, 2021; and 2,628.0000 RSUs will vest on February 12, 2022. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,150.3887 RSUs vested on February 19, 2019; 3,683.0826 RSUs will vest on February 14, 2020; 2,747.2827 RSUs will vest on February 13, 2021; and 2,628.0000 RSUs will vest on February 12, 2022. Read SEC document
February 19, 2019 Filed Feb 21, 2019 17:25 UTC	Zoetis Inc. ZTS · Entity 679	OtherCommon Stock	1,041	$94.91	$98,801.31	Disclosure SEC source: 0001555280-19-000106 · wf-form4_155078791845431.xml · nonDerivative · entry 2 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,009 F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date. Read SEC document
February 19, 2019 Filed Feb 21, 2019 17:25 UTC	Zoetis Inc. ZTS · Entity 679	Exercise / conversionCommon Stock	4,150	Not disclosed	Not disclosed	Disclosure SEC source: 0001555280-19-000106 · wf-form4_155078791845431.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document
February 12, 2019 Filed Feb 14, 2019 18:51 UTC	Zoetis Inc. ZTS · Entity 679	GrantRestricted Stock Unit · Derivative	2,628	$0.00	$0.00	Disclosure SEC source: 0001555280-19-000046 · wf-form4_155018827571483.xml · derivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,208.754 Underlying: Common Stock · 2,628 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 4,150.3887 RSUs will vest on February 19, 2019; 3,683.0826 RSUs will vest on February 14, 2020; 2,747.2827 RSUs will vest on February 13, 2021; and 2,628.0000 RSUs will vest on February 12, 2022. Read SEC document
January 18, 2019 Filed Jan 22, 2019 17:02 UTC	Entasis Therapeutics Holdings Inc. ETTX · Entity 16036	GrantStock Option (right to buy) · Derivative	15,000	$0.00 Strike: $5.66	$0.00	Disclosure SEC source: 0001209191-19-004772 · doc4.xml · derivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-01-17 F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on January 1, 2020, subject to the Reporting Person continuing to provide service through such date. Read SEC document
March 13, 2018 Filed Mar 14, 2018 16:55 UTC	NanoString Technologies Inc NSTG · Entity 15988	GrantCommon Stock	10,000	$6.93	$69,300.00	Disclosure SEC source: 0001401708-18-000071 · wf-form4_152106089417093.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $6.900 to $6.965, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. Read SEC document
February 27, 2018 Filed Mar 1, 2018 17:25 UTC	Zoetis Inc. ZTS · Entity 679	Exercise / conversionRestricted Stock Unit · Derivative	3,771.06	Not disclosed	Not disclosed	Disclosure SEC source: 0001555280-18-000121 · wf-form4_151994313793062.xml · derivative · entry 3 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,514.1921 Underlying: Common Stock · 3,771.06 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,771.0600 RSUs vested on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,771.0600 RSUs vested on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 3,771.0600 RSUs vested on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021. Read SEC document
February 27, 2018 Filed Mar 1, 2018 17:25 UTC	Zoetis Inc. ZTS · Entity 679	OtherCommon Stock	946	$81.67	$77,259.82	Disclosure SEC source: 0001555280-18-000121 · wf-form4_151994313793062.xml · nonDerivative · entry 2 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,900 F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date. Read SEC document
February 27, 2018 Filed Mar 1, 2018 17:25 UTC	Zoetis Inc. ZTS · Entity 679	Exercise / conversionCommon Stock	3,771	Not disclosed	Not disclosed	Disclosure SEC source: 0001555280-18-000121 · wf-form4_151994313793062.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document
February 13, 2018 Filed Feb 15, 2018 17:11 UTC	Zoetis Inc. ZTS · Entity 679	GrantRestricted Stock Unit · Derivative	2,730	$73.24	$199,945.20	Disclosure SEC source: 0001555280-18-000070 · wf-form4_151873270118686.xml · derivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,285.2521 Underlying: Common Stock · 2,730 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 3,771.0600 RSUs will vest on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021. Read SEC document
January 01, 2018 Filed Jan 3, 2018 18:20 UTC	NanoString Technologies Inc NSTG · Entity 15988	GrantCommon Stock · Derivative	10,168	$0.00 Strike: $7.47	$0.00	Disclosure SEC source: 0001401708-18-000014 · wf-form4_151502158609950.xml · derivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,168 Underlying: Common Stock · 10,168 shares Expires 2027-12-31 F1 · derivative.exercise_date: 100% of the shares subject to the Option vest on the one year anniversary of January 1, 2018. The vesting of shares subject to the Option will accelerate in full upon a "change in control" as defined in the 2013 Equity Incentive Plan. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.